Although impaired insulin signaling in AD is distinct from that in diabetes mellitus, the peripheral glycolysis‐related alterations identified in our analysis may represent an early warning sign of broader systemic endocrine changes that reflect underlying neuroendocrine disturbances. Here, INS is linked to Alzheimer disease.